When you buy from enQuire, you are harnessing the knowledge and experience of their team to let you focus on the next scientific breakthrough, not your reagents.
You will be able to have complete confidence in your purchase because they will go beyond traditional validation in several applications so that you can select better antibodies for your experiments and speed through antibody optimisation.
There are numerous reasons antibodies don’t work. The reagent may have been designed poorly or a new lot may not have been tested properly.
Another antibody may just be more appropriate for the experiment you’re running. Many, if not all of these issues may be addressed by better validation.
You can rely on enQuire Bio, the industry experts.
Leading purity, activity, and supporting data, without the high prices.
1st to market Mass Spec & Protein Array Validated Abs.
cGMP Antibodies for IVD.
cGMP CE Marked for the EU
Pre-Designed and tested siRNA
TranslationBlockerTM siRNA is the only pre-designed siRNA with confirmed reduction of specific protein levels.
Guaranteed knockdown – with published results. 3rd party validated.
We will only sell you the very best reagents in the world.
When you buy from enQuire, you are harnessing the knowledge and experience of our team to give you exactly what you need to find the next scientific breakthrough. When we make a product, or source it from an exceptional researcher or manufacturer, we will tell you why we chose that exact product. You will know what you are buying and why you are buying it from us. You will be able to have complete confidence in your purchase. We will never break our promises to you.
You can’t test specificity by just looking at what an antibody binds. You also have to confirm what it doesn’t bind. We did that against 20,000 human proteins. Our data supported specificity will help you avoid costly, confounding antibody cross-reactivity problems.
We are the first company in the world to introduce Mass Spec antibody validation. Our Mass Spectometry based antibody validation process allows us to quantitatively measure antibody specificity because you rely on our claims of specificity in IHC. These antibodies are made in large lots in bioreactors ensuring high reproducibility and low levels of contaminants commonly resulting from traditional culture methods.
Our Immunohistochemistry antibodies are the first products of their kind to receive Mass Spec validation. Each antibody is validated in at least one relevant tissue section and reviewed by independent clinical pathologists as well as by our own experienced team. As with our MS-QAVA™ mAbs, these antibodies are manufactured in large lots in bioreactors to ensure excellent specificity, sensitivity, and reproducibility. We are currently also undertaking unprecedented testing of these antibodies in protein arrays to confirm specificity and identify potential non-specific interactions.
We carry the top published monoclonal antibodies for widely used cell markers for the research market. These antibodies are carefully conjugated and purified to ensure bright, specific signals and are repeatedly tested to ensure excellent performance on any instrumentation. Our Flow Antibodies are available in a wide array of conjugates including dyes for the 405nm violet laser as well as tandem dyes to facilitate bigger multicolor panels. Ask us about discounts on panels of 3 or more antibodies using the chat box below!
Our ELISA/CLIA antibodies bring clinical level validation to our reagents. They are tested in dozens of unique samples and compared to the leading diagnostic tests for important clinical targets. These reagents are suitable for research use or may be used as components for in vitro diagnostic (IVD) kits following additional regulatory testing and submittal by the purchaser. These are guaranteed to be the highest quality ELISA antibodies you’ve ever purchased. Substantial bulk discounting is available for clinical users and IVD manufacturers.
There are numerous reasons antibodies don’t work. The reagent may have been designed poorly. A new lot may not have been tested properly. Another antibody may just be more appropriate for the experiment you’re running. Many, if not all of these issues may be addressed by better validation. We will go beyond traditional validation in a few applications so that you can select better antibodies for your experiments and speed through antibody optimization.